Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,231.8
-7.4 (-0.23%)

 

  • STI Straits Times Index
    3,231.8
    -7.4 (-0.23%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,593.5
    -3.7 (-0.23%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,323.7
    -247.8 (-0.93%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,909.9
    4.6 (0.16%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,141.5
    -178.3 (-0.76%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,098.9
    -43.6 (-0.71%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,139.2
    16.8 (0.79%)
    Index delayed 20 minutes
  • XAO XAO
    6,840.8
    35.2 (0.52%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,018.9M
  • Value: 1,045.8M
  • Rise: 152
  • Fall: 171
  • Unch: 506

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.198+0.005
Golden Agri-Res0.245-0.020
YZJ Shipbldg SGD0.970+0.015
Tritech0.029+0.005
Mapletree NAC Tr1.150-0.010
BreadTalk0.620+0.080
Yoma Strategic0.375+0.050
ComfortDelGro2.320-0.060
Ascendas Reit2.900-0.020
AusGroup^0.030-0.002

World Indices

World Indices
Name Last Change
Nasdaq 8,482.1 -4.0
HSI 26,323.7 -247.8
HSCEI 10,427.4 -91.7
Jakarta 6,098.9 -43.5
Nikkei 225 23,141.5 -178.3
SSE Comp 2,909.9 +4.6
Shanghai A 3,048.6 +4.9
Shanghai B 258.2 -0.4
PSE Comp 0.0
KOSPI 2,139.2 +16.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AUSTRALIAN PRIMARY HEMP LTD AUSTRALIAN PRIMARY HEMP
Updated on 14 Nov 2019 (End of trading day)
Last (AUD): 0.180 Change: -0.020 High: 0.180 Remarks: -
Change (%): -10.00 Low: 0.180
Open 0.180 Yesterday's Close 0.19999999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 657 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.00742 Trailing EPS (AUD) e -0.00742 NAV (AUD) b 0.0188
PE a - Trailing PE f - Price / NAV b 9.5745
Dividend (AUD) d - Cash In Hand (AUD) g 0.0088 Issued & Paid-up Shares c 69,530,100
Dividend Yield (%) d - Price / Cash In Hand g 20.455 Treasury Shares h -
Beta - 75 Daysi 3.424 R-Squared - 75 Days(%)i 4.36 Market Cap (M) 12.515
Beta - 500 Daysi 3.490 R-Squared - 500 Days (%)i 4.13 Enterprise Value (M) 11.906
Piotroski F Score 2 Exchange Code APH Par Value ( AUD ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 15 Oct 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AUSTRALIAN PRIMARY HEMP LTD ASX 12.515 - - 9.5745 -
Industry Biotechnology ASX 2,508.733 56.143 55.924 14.7805 0.941
Local Peer CSL ASX 122,394.584 45.620 45.620 16.3560 0.984
Local Peer POLYNOVO LIMITED ASX 1,447.783 - - 55.4430 -
Local Peer AVITA MEDICAL LTD ASX 1,126.310 - - 37.8205 -
Local Peer MESOBLAST LTD ASX 949.059 - - 1.3845 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 489.164 - - 11.5351 -
Local Peer TELIX PHARMACEUTIC ASX 468.568 - - 10.8441 -
Local Peer NEXT SCIENCE LTD ASX 410.409 - - 11.7980 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 269.274 87.613 - 16.0517 -
Local Peer RESAPP HEALTH LIMITED ASX 187.989 - - 24.5455 -
Local Peer PHYLOGICA LIMITED ASX 154.059 - - 24.7826 -
Local Peer CYNATA THERAPEUTICS LTD ASX 126.197 - - 11.5023 -
Local Peer IMUGENE LIMITED ASX 151.824 - - 5.5263 -
Other Local Peers ONCOSIL MEDICAL LIMITED (ASX), ORTHOCELL LIMITED (ASX), BIONOMICS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), BIOTRON (ASX), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), ADALTA LTD (ASX), PATRYS LIMITED (ASX), REGENEUS LTD (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), CELLMID LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), IMMUTEP LTD (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 130,524.399 15.550 16.180 11.9451 2.547
Global Peer GILEAD SCIENCES INC NASDAQ 80,121.950 14.688 29.752 3.8887 3.648
Global Peer CELGENE CORP NASDAQ 78,580.343 19.422 13.364 6.5012 -
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer VERTEX PHARMACEUTICAL NASDAQ 53,255.765 25.403 24.842 10.1374 -
Global Peer BIOGEN INC NASDAQ 50,864.795 11.480 9.427 3.6343 -
Global Peer ILLUMINA INC NASDAQ 43,838.340 53.073 45.055 9.8757 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 38,241.936 15.645 17.835 3.6406 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 23,878.551 75.565 22.275 5.0302 0.794
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 23,706.905 305.501 16.124 2.2867 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), SINO BIOPHARM (HKEx), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), EXACT SCIENCES CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GENSCRIPT BIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), 3SBIO (HKEx), MIRATI THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ALKERMES PLC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), HAOHAI BIOTEC (HKEx), MOMENTA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), VIELA BIO INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), EDITAS MEDICINE INC (NASDAQ), VERACYTE INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CKLIFE SCIENCES (HKEx), ARVINAS INC (NASDAQ), ALECTOR INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), OPKO HEALTH INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), KODIAK SCIENCES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NEXTCURE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), OMEROS CORP (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ASCLETIS-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), TRANSLATE BIO INC (NASDAQ), RETROPHIN INC (NASDAQ), SINOMAB BIO-B (HKEx), MEIRAGTX HOLDINGS PLC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MYOVANT SCIENCES LTD (NYSE), CHEMOCENTRYX INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), STEMLINE THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), SINOVAC BIOTECH LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), MERUS B V (NASDAQ), DERMIRA INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MACROGENICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), MERIDIAN BIOSCIENCE INC COM (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), PERSONALIS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), LEE'S PHARM (HKEx), BELLUS HEALTH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), GERON CORP (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), PFENEX INC (NYSE American), DPHARMA (Bursa), SORRENTO THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), BBI LIFE SCI (HKEx), AFFIMED N V (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), UNI-BIO GROUP (HKEx), FIVE PRIME THERAPEUTICS (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), MERSANA THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), IVERIC BIO INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), IMV INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), SESEN BIO INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), FORTRESS BIOTECH INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CHIMERIX INC (NASDAQ), NOVAVAX INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), NANTKWEST INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), COHBAR INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BIOXCEL THERAPEUTICS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SYNLOGIC INC (NASDAQ), VERASTEM INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), VACCINEX INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), OPIANT PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VERMILLION INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), EQUILLIUM INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), ORGENESIS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CURIS INC (NASDAQ), CT ENTERPRISE (HKEx), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), INMUNE BIO INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PORT (SET), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), BELLICUM PHARMACEUTICALS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), REGENT PACIFIC (HKEx), SAVARA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOCARDIA INC (NASDAQ), BIOSINO BIO-TEC (HKEx), CONTRAFECT CORP (NASDAQ), ORAGENICS INC (NYSE American), EXTRAWELL PHAR (HKEx), MICROBOT MEDICAL INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), VAXART INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), TOCAGEN INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), IBIO INC (NYSE American), PRECIPIO INC (NASDAQ), Suntar Eco-City^ (SGX), DARE BIOSCIENCE INC (NASDAQ), TROVAGENE INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 20 ORD SHS (NASDAQ), MEGASUN (Bursa), OCUGEN INC (NASDAQ), ADVAXIS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ENDRA LIFE SCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), HAO WEN HLDGS (HKEx), CAPRICOR THERAPEUTICS INC (NASDAQ), MGRC (Bursa), PHIO PHARMACEUTICALS CORP (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SPHERIX INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.025
+16.13 %
10 Days --0.005
-2.70 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.150 - 0.350 Change From 1 Year Low +0.030 % Change From 1 Year Low (%) +20.00
Change From 1 Year High -0.170 % Change From 1 Year High (%) -48.57
2 Years Range 0.150 - 0.350 Change From 2 Years Low +0.030 % Change From 2 Years Low (%) +20.00
Change From 2 Years High -0.170 % Change From 2 Years High (%) -48.57
5 Years Range 0.150 - 0.350 Change From 5 Years Low +0.030 % Change From 5 Years Low (%) +20.00
Change From 5 Years High -0.170 % Change From 5 Years High (%) -48.57
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Australian Primary Hemp Ltd. is a biotechnology company, which engages in developing new human therapeutics based on its proprietary drug discovery, drug targeting and synthesis technologies. It involves in the research and development of new human pharmaceuticals. The company also engages in the commercialization and improvements of its generic fondaparinux product. Its products include fondaparinux sodium, hyact and ha-irinotecan. Australian Primary Hemp was founded by Tracie Rams dale in 1995 and is headquartered in Melbourne, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
14 Nov 2019 0.180 0.180 0.180 0.180 657 -
13 Nov 2019 0.210 0.210 0.200 0.200 25,658 -
12 Nov 2019 0.220 0.220 0.210 0.210 12,334 -
11 Nov 2019 0.180 0.200 0.175 0.200 111,240 -
08 Nov 2019 0.150 0.170 0.150 0.170 12,363 -
07 Nov 2019 0.155 0.155 0.155 0.155 12,000 -
06 Nov 2019 0.170 0.170 0.150 0.155 6,568 -
05 Nov 2019 0.185 0.185 0.180 0.180 28,253 -
04 Nov 2019 0.185 0.185 0.185 0.185 66,747 -
01 Nov 2019 0.185 0.190 0.185 0.190 104,178 -
31 Oct 2019 0.210 0.210 0.185 0.185 197,593 -
30 Oct 2019 0.200 0.200 0.195 0.195 66,472 -
29 Oct 2019 0.200 0.200 0.200 0.200 23,100 -
28 Oct 2019 0.215 0.215 0.195 0.200 280,158 -
25 Oct 2019 0.220 0.230 0.195 0.200 121,180 -
24 Oct 2019 0.190 0.230 0.190 0.195 118,390 -
23 Oct 2019 0.220 0.220 0.195 0.195 458,752 -
22 Oct 2019 0.270 0.270 0.220 0.225 329,001 -
21 Oct 2019 0.280 0.305 0.255 0.270 351,547 -
18 Oct 2019 0.315 0.350 0.245 0.275 1,133,899 -
Summary
Current 2 Weeks
(01 Nov 2019 to 14 Nov 2019)
0.185 0.220 0.150 0.180 379,998 -
Previous 2 Weeks
(18 Oct 2019 to 31 Oct 2019)
0.315 0.350 0.150 0.185 3,080,092 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.